In-Motion Webinar: Bionano will host a webinar featuring the study’s lead author, Dr. Guilin Tang, who will discuss the study and its findings in detail, including a summary of the potential ...

Under the private placement, Bionano (BNGO) will issue Series A warrants and Series B warrants, allowing investors to purchase up to ~35.0M shares of its common stock at $0.571 per share.

Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will market and commercialize Bionano’s VIA™ software to Revvity’s next generation ...

At Bionano, we’re on a mission to transform the way the world sees the genome. Our genome mapping systems provide sensitive, unbiased, genome-wide structural variant detection, and our genomic ...

Bionano Reports Inducement Grant Under Nasdaq Listing Rule 5635 (c) (4) PRESS RELEASE GlobeNewswire Sep. 22, 2023, 04:05 PM ...

The inverted duplication [GRCh38] Xq22.2 (103734669_103958435)×2 contains the genes PLP1 (OMIM:300401), RAB9 (OMIM:300285), TMSB15B (OMIM:301011) and a lamina-associated domain (LAD), while the tandem ...

Bionano Genomics, Inc. today announced the Stratys™ system for high throughput optical genome mapping (OGM) and VIA™ software for visualization, interpretation and reporting of genome analysis ...

Bionano sold 4,781 nanochannel array flow cells in the fourth quarter, which was up 49% from 4Q2021. For the year, the company sold 15,375 flow cells, a 23% improvement from FY2021.

BioNano reported quarterly sales of $8.21 million, which beat the analyst consensus estimate of $8 million by 2.69%. This sales figure represents a 30.4% increase over sales of $6.3 million in the ...